Interferon and Ribavirin Treatment in Patients With Hemoglobinopathies
NCT00887081
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
150
Enrollment
OTHER
Sponsor class
Conditions
Hemoglobinopathies
Interventions
DRUG:
PEG-IFN alpha2a or PEG-IFN alpha2b and Ribavirin
Sponsor
Azienda Ospedaliera V. Cervello